Ingefy — AI Stock Screener & Autonomous Investment Analyst
AI Stock Screener — Autonomous Investment Research

You Spotted 50 Stocks.
Analyzed 5. Missed 45.

Your opportunity cost is invisible — until you miss NVIDIA at $50. Ingefy screens thousands of stocks with the rigor you'd apply yourself, at a scale you never could.

Start Free — 3 Days Tour the Platform
3-day free trial · No credit card required
INGEFY — Screening Results · 3,247 Analyzed
Buffett Checklist · 14 proposals ranked
Completed 06:42 AM  ·  S&P 500 + NASDAQ
NVDA
NVIDIA Corporation
Strong Buy
Conviction15/17
DCF Fair Value
$892
Margin of Safety
+24%
P/E vs Sector
38.2x
FCF Growth
+41%
MSFT
Microsoft Corporation
Buy
Conviction13/17
DCF Fair Value
$442
Margin of Safety
+18%
ROE (3yr)
38.4%
Revenue CAGR
+14%
BRK.B
Berkshire Hathaway
Watch
Conviction11/17
DCF Fair Value
$374
Margin of Safety
+6%
P/B Ratio
1.4x
Debt/Equity
0.28
87%
Average Conviction Score
<1h
To Screen 5,000+ Stocks
24/7
Analyzes While You Sleep
0
Emotional Bias
01
The Opportunity Cost

You're losing money
on stocks you never analyzed.

You spotted 50 interesting stocks this month. You had time to analyze 5. The other 45? That's your opportunity cost. The one that never shows up in your portfolio — because it was never in it.

You found NVIDIA at $50 in 2016. But you were buried in AAPL financials. Six months later, it doubled. You watched from the sidelines.

With Ingefy

Screen thousands of stocks against your own criteria in under an hour. Every morning, your top candidates — ranked by conviction. Zero missed opportunities.

Screens S&P 500, NASDAQ, CAC 40, Europe — simultaneously
Filters by your exact criteria, not a generic algorithm
Proposals ranked by conviction score every morning
Never miss an opportunity again
INGEFY — Screening · 3,247 stocks processed
Buffett Checklist Results
Apr 15 · 06:42 AM
#1
NVDA
NVIDIA
88%
Strong Buy
+24%
#2
MSFT
Microsoft
76%
Buy
+18%
#3
AAPL
Apple Inc.
71%
Buy
+12%
#4
V
Visa Inc.
68%
Watch
+7%
#5
MA
Mastercard
65%
Watch
+5%
3,242 filtered out · 5 passed your criteria
02
The -20% Panic Sale

You sell in panic
because you never wrote your thesis.

March 2020. The market drops 30%. Paul sells META at $150 in panic. 18 months later, the stock hits $350. Paul had never written his investment thesis. He had an intuition — not a conviction.

Without a written thesis, your brain rewrites the story every time the price moves. Conviction isn't a feeling. It's a document.

With Ingefy

A 5,000+ word analysis report: business model, competitive moat, risks, valuation scenarios. Written black on white. So when the next correction hits, you know exactly what you own — and why.

5,000+ word Quality report: moat, management, risks, scenarios
Multi-method valuation: DCF, Reverse DCF, EV/EBITDA, P/FCF
Written to YOUR investment philosophy, not a generic template
Build conviction before the next correction
INGEFY — Quality Report · META
META
Meta Platforms Inc. · NASDAQ
87%
Conviction Score
9.2/10
8.1/10
7.8/10
Valuation — 3 Scenarios
DCF Base
$672
+21% upside
DCF Bull
$920
+65% upside
EV/EBITDA
$590
+6% upside
P/FCF
$615
+10% upside
Competitive Moat — Strong
Network effects across 3.2B+ users create insurmountable switching costs. Ad tech infrastructure generates sustainable margin expansion…
03
The Subscription Stack

$115/month.
For tools that don't talk to each other.

You pay $30 for a screener. $25 for fundamental analysis. $40 to read 10-K filings. $20 for a valuation model.

= $115/month for fragmented tools with incompatible data. You copy-paste between 5 tabs. You lose context. You make decisions on incomplete pictures.

With Ingefy

One subscription. Screening, fundamentals, document analysis, DCF valuation, portfolio tracking — all integrated, all sharing the same data source. Starting at $9/month.

Replaces: screener + fundamental data + 10-K reader + valuation tool
All tools share the same financial data — no inconsistencies
From $9/month annual — vs $115+/month for separate tools
See what's included
INGEFY — All Tools · One Platform
Screening
Key Financials
Valuation
10-K Analysis
Portfolio
Included in every plan
Stock Screener (5,000+ stocks)
FREE ∞
30-Year Key Financials
FREE ∞
DCF + Multiples Valuation
FREE ∞
Portfolio vs S&P 500
FREE ∞
AI Quality Report (5,000+ words)
1 CREDIT
10-K / Earnings Call Analysis
1 CREDIT
04
The Data Gap

Professionals have Bloomberg.
You have 5 browser tabs.

Bloomberg Terminal: $25,000/year. It gives institutional investors 30 years of financial history, real-time ratios, earnings transcripts, and SEC filings — in a single interface.

You get a free Yahoo Finance page with 5 years of data and three paywalls in your way.

With Ingefy

30+ years of financial history from FMP Premium. Balance sheets, income statements, ratios, dividends, earnings transcripts, SEC 10-K filings — all in one place. The data edge, without the Bloomberg price tag.

30+ years of fundamentals: margins, CAGR, ROE, ROIC, FCF
106 financial metrics with fuzzy search and Chart Builder
10-K filings + earnings call transcripts for 5,000+ stocks
Get institutional-grade data
INGEFY — Key Financials · AAPL · 30yr
AAPL
Apple Inc. · 1994 → 2024
Revenue
FCF
EPS
19942000200820162024
Revenue CAGR 10Y
+11.4%
FCF Margin
26.8%
ROE (3yr avg)
147%
Gross Margin
44.1%
EPS CAGR 5Y
+18.2%
Debt/Equity
1.72
05
The Performance Gap

80% of retail investors
underperform the S&P 500.

Not because of lack of intelligence. Not because markets are random. But because most investors have no process. They chase hype, sell in panic, and buy back at highs.

Buffett doesn't outperform because he's smarter. He outperforms because he has a systematic, reproducible process — and he sticks to it.

With Ingefy

Analyze like Buffett, Graham, Lynch — or define your own process. Discovery mode surfaces the best opportunities in your universe. SuperInvestors section shows what the legends are buying. Your portfolio tracks performance vs. S&P 500 in real time.

6 legendary investor templates: Buffett, Graham, Lynch, GARP, Momentum, Dividend
SuperInvestors: see Buffett, Ackman, Li Lu 13F filings in one place
Portfolio vs. S&P 500 benchmark — see your alpha in real time
Start investing with a process
INGEFY — SuperInvestors & Templates
Buffett
Value · Moat
Graham
Deep Value
Lynch
Growth · GARP
SuperInvestors — Latest 13F
WB
Warren Buffett
Berkshire Hathaway
+AAPL
Q1 2025
BA
Bill Ackman
Pershing Square
+GOOGL
Q1 2025
LL
Li Lu
Himalaya Capital
+BYD
Q1 2025
Your portfolio vs S&P 500 YTD
+18.4%Your portfolio
+12.1%S&P 500
06
Discovery Mode

The next Airbnb is already listed.
Your brain hasn't found it yet.

Research shows investors systematically over-invest in companies they already know. It's called the familiarity bias — and it's your invisible leak.

The best opportunities aren't in your head. They're in the 4,500 stocks you've never looked at.

With Ingefy

Discovery Mode applies your checklist to the entire market — not just the names you know. Every week, it surfaces stocks that match your strategy, ranked by conviction, from universes you'd never screen manually.

A human realistically follows 20–50 stocks. Your agent scans 5,000+.
Familiarity bias: you invest in what you know. You miss what matters.
Systematic discovery vs. intuition — a 200-stock edge every cycle.
Find what you've been missing
INGEFY — Discovery Mode · Graham Strategy
Discoveries of the Week
4,213 scanned
#1
CAVA
CAVA Group Inc.
NEW
91%
+31%
MoS
#2
CELH
Celsius Holdings
87%
+28%
MoS
#3
INSP
Inspire Medical Systems
83%
+22%
MoS
#4
SFM
Sprouts Farmers Market
79%
+18%
MoS
✦ Outside your usual radar
None of these 4 tickers appear in the 50 most-followed stocks. Your checklist found them. Your brain never would have.
What's Always Free

Screening, Fundamentals & Valuation
Free & Unlimited.

Only the AI Quality Report (5,000+ words) and Document Analysis cost 1 credit. Everything else is unlimited on all plans.

Free & Unlimited

All the tools you need to research any stock

Stock Screener — 5,000+ stocks with custom criteria
30-Year Key Financials — every ratio, every year
DCF + Reverse DCF + Multiples Valuation
Portfolio vs S&P 500 Performance Tracking
Watchlist with live upside tracking
SuperInvestors 13F filings (Buffett, Ackman, Li Lu…)
6 Investor Templates (Buffett, Graham, Lynch…)
Chart Builder — 106 fundamental metrics
1 Credit per Use

Deep AI analysis, on demand

AI Quality Report — 5,000+ words calibrated to YOUR criteria. Validates your thesis — and surfaces what you missed.
Document Analysis — Structured breakdown per your checklist: key issues, risks, CEO commentary. Set your watchpoints, get what matters.
€3 = 1 analysis · €15 = 5 analyses · €30 = 10 analyses vs. €150–300/hour for a junior analyst
Pricing

Analyst-grade research.
Not analyst-grade fees.

One junior analyst costs €150–300/hour. A full report from Ingefy costs €3. Start free for 3 days — no credit card required.

Essentiel
9
/month, billed annually
or €19/month
4 in-depth analyses/month. 1 Bloomberg terminal report costs more than your annual plan.
Full stock screener (S&P 500, NASDAQ, CAC 40, Europe)
30-year key financials & Chart Builder
DCF + Multiples valuation tools
SuperInvestors 13F filings
1 credit/week (AI Quality Report or Document Analysis)
Portfolio tracking not included
Start Free — 3 Days
3-day trial · Cancel anytime
Premium
29
/month, billed annually
or €39/month
12 in-depth analyses/month + early access to new features. For serious investors who leave nothing to chance.
Full stock screener (S&P 500, NASDAQ, CAC 40, Europe)
30-year key financials & Chart Builder
DCF + Multiples valuation tools
SuperInvestors 13F filings
3 credits/week (AI Quality Report or Document Analysis)
Portfolio tracking vs. S&P 500
Early beta access to new features
Start Free — 3 Days
3-day trial · Cancel anytime
Bloomberg Terminal
$25,000/year
Screener + Data + Valuation stack
~$115/month
Junior analyst (1 report)
€150–300
Ingefy
from €9/month
Built by an investor, for investors

Stop missing opportunities.
Start investing with a process.

Your edge is your process. Ingefy executes it at scale — so every stock in your universe gets the analysis it deserves.

Start Free — 3 Days
3-day free trial Cancel anytime No credit card required

Ingefy is a decision-support tool, not a licensed financial advisor. Past performance is not indicative of future results. You are solely responsible for all investment decisions.

How Ingefy Compares

The best AI stock screener
isn't generic.

Every tool claims to use AI. Most give you a score. Only Ingefy applies your investment checklist — autonomously, every night, across your entire universe.

Ingefy is an AI stock screener that combines a custom investment checklist engine, multi-method valuation (DCF, multiples, DDM), and 5,000+ word deep analysis reports — all run autonomously overnight by an AI agent. No other tool gives value investors this combination of customization, depth, and automation.

Feature
Ingefy
Fiscal AI Seeking Alpha Danelfin
Custom investment checklist ⚠️
Multi-method valuation (DCF, Multiples, DDM) ⚠️
Deep analysis reports (5,000+ words) ⚠️
Qualitative analysis (Moat, Management, ESG) ⚠️ ⚠️ ⚠️
Investor philosophy templates (Buffett, Graham…)
Covers S&P 500, NASDAQ, CAC 40, Europe
Transparent public pricing
AI agent screens + analyzes + proposes autonomously ⚠️ ⚠️ ⚠️
Full support ⚠️ Partial / limited Not available
Try the AI Stock Screener Free 3-day free trial · No credit card required
FAQ

Frequently Asked Questions

Everything you need to know before starting

Ingefy is an AI stock screener built specifically for value investors. Unlike generic tools that give you a score, Ingefy lets you define your own investment checklist — with custom qualitative and quantitative criteria — and runs it autonomously against 5,000+ stocks every night. It combines multi-method valuation (DCF, reverse DCF, EV/EBITDA, P/FCF, DDM) with 5,000+ word deep analysis reports styled to your investment philosophy. Templates for Buffett, Graham, Lynch, GARP, Momentum, and Dividend Growth are included. The result: conviction-ranked proposals every morning, with full transparency on which criteria each stock passed or failed.

With Ingefy, automating stock analysis takes three steps: (1) Define your investment checklist — set qualitative criteria (moat, management, ESG) and quantitative thresholds (ROE, FCF growth, debt levels). (2) Choose your stock universe — S&P 500, NASDAQ, CAC 40, Europe, or custom tickers. (3) The AI agent runs overnight, screens every stock against your criteria, calculates intrinsic value using multiple valuation methods, and generates full analysis reports. You wake up to ranked proposals. No manual prompting, no spreadsheets — fully automated investment research.

Yes — when the AI is guided by your investment philosophy. Ingefy applies value investing principles through a custom checklist modeled on legendary investors like Buffett, Graham, or Lynch. The AI calculates intrinsic value via DCF and multiples, assesses qualitative factors like competitive moats and management quality, and ranks stocks by margin of safety. The AI doesn't replace your judgment — it scales your process. You define the criteria; the AI executes them across 5,000+ stocks simultaneously.

Serious value investors typically need: a stock screener (to filter by fundamentals), a valuation tool (DCF and multiples), a source for 30-year historical financials, qualitative analysis (moat, management, ESG), and a way to track their portfolio vs. benchmarks. Most use 4–6 separate tools. Ingefy combines all of these — plus an autonomous AI agent that runs your full checklist overnight and proposes the strongest candidates every morning. Starting at €9/month, it replaces $160+/month in individual tool subscriptions.

The screener, 30-year key financials, Chart Builder (106 metrics), DCF + Multiples valuation, Portfolio vs. S&P 500, Watchlist, SuperInvestors 13F, and all 6 investor templates are free and unlimited on every plan. Only the AI Quality Report and Document Analysis cost 1 credit each.

A credit unlocks one AI Quality Report (5,000+ word deep analysis) or one Document Analysis. Buy as packs: €3 = 1 analysis · €15 = 5 · €30 = 10 — vs. €150–300/hour for a junior analyst.

Real-time financial data via Financial Modeling Prep Premium: balance sheets, income statements, financial ratios, price history, and dividends going back 30+ years. Enriched with 10-K SEC filings and earnings call transcripts. Smart cache: fundamental data refreshed every 24h, prices updated every minute.

No. Ingefy analyzes like you, not for you. The agent applies YOUR checklist, YOUR criteria thresholds, and YOUR investment philosophy. It surfaces opportunities and builds conviction — but the final decision is always yours.

5,000+ stocks across S&P 500, NASDAQ, CAC 40, European markets, and custom tickers. The screener processes your entire universe against your criteria in minutes. You get ranked proposals — not a raw list.

Both. Pricing is available in EUR and USD at the same rates. The currency is selected automatically based on your location at checkout, or you can switch manually.

Yes. Cancel in 2 clicks from Settings. No commitment, no friction, no customer service loop. Your access continues until the end of the billing period.

Yes. Secure authentication, AES-256-GCM encrypted data at rest, no data shared with third parties. Your investment strategy and criteria are private — they never leave our servers.

You can. But here's what it actually costs to replicate Ingefy: Claude Pro ($20/mo), Gemini Advanced ($20/mo), Perplexity Pro ($20/mo), AND Financial Modeling Prep API ($100/mo). That's $160+/month in subscriptions — before writing a single prompt. Ingefy starts at $9/month with your investment thesis, your criteria, and your checklist already built in. The real cost of DIY isn't the subscriptions. It's the hours spent prompting, re-prompting, and stitching together numbers that no tool ever makes coherent. What Ingefy does that no AI can do from scratch: screen 500+ stocks while you sleep, score conviction against YOUR checklist, track your live portfolio, run DCF + Multiples + DDM in one consistent framework, and surface gems in Discovery Mode you'd never think to look for. AI is the tool. Ingefy is the analyst.